All articles tagged with #childhood cancer
Fernando Goldsztein, whose son Frederico was diagnosed with medulloblastoma, has dedicated his life to finding a cure for this rare childhood brain tumor by founding the Medulloblastoma Initiative, which has raised $13 million and is working on new clinical trials to improve treatment options for affected children worldwide.
Fernando Goldsztein, whose son Frederico was diagnosed with medulloblastoma, a rare and aggressive childhood brain tumor, has dedicated his life to finding a cure by founding the Medulloblastoma Initiative, which has raised $13 million and is conducting clinical trials to develop new treatments, aiming to save not only his son but thousands of other children affected by this disease.
Researchers have discovered that a rare childhood cancer, MPNST, relies heavily on sugar metabolism via the pentose phosphate pathway, and inhibiting this pathway could lead to new targeted therapies. However, experts caution against drastic sugar restrictions in children's diets, emphasizing the importance of consulting healthcare professionals for personalized treatment and nutrition plans.
A toddler named Jonny was diagnosed with a rare and aggressive cancer called malignant rhabdoid tumor after experiencing frequent infections, but through personalized treatment, he responded well and is now in remission, highlighting the importance of early detection and specialized care in rare pediatric cancers.
Research suggests planned C-sections may increase the risk of childhood leukemia, particularly B-cell acute lymphoblastic leukemia, though the overall risk remains low. The study highlights differences between planned and emergency C-sections and emphasizes the importance of medically necessary procedures while considering potential long-term health impacts.
A two-year-old boy named Zak from Crawley, West Sussex, was diagnosed with acute lymphoblastic leukaemia after a stubbed toe led to a blood test. His treatment includes intensive chemotherapy and regular lumbar punctures. Despite the challenges, Zak remains active and joyful, finding comfort in a lavender-scented teddy bear provided by Cancer Support UK. His family is involved in a campaign to raise funds for the charity to provide more bears to children undergoing treatment.
Four-year-old Kataleya, who was diagnosed with Ewing sarcoma at age 3, celebrated the end of her cancer treatment by walking down a pink carpet and ringing the bell at MemorialCare Miller Children's & Women's Hospital in California. Cheered on by doctors, nurses, and staff, she wore a pink crown and gave a big smile after ringing the bell. Kataleya underwent chemotherapy and a 16-hour surgery as part of her treatment, and her journey was shared on Instagram by the nonprofit organization Little Wishes.
Fernando Goldsztein, a father from Brazil, is leading fundraising efforts to find a breakthrough cure for his son Frederico's Medulloblastoma, the most common brain cancer in children. Teaming up with doctors at Children’s National Medical Center in Washington D.C., they have formed the Medulloblastoma Initiative to focus on developing better therapies for this deadly form of brain cancer. They are on the verge of two FDA approved treatments that could result in a cure and fewer side effects for children facing treatment, offering hope to the 500 families affected by this diagnosis each year.
Seven-year-old Aubrey Rothery has been diagnosed with an inoperable and deadly brain tumour called diffuse midline glioma (DIPG), which typically kills most sufferers within a year. His parents initially dismissed his balance issues as a result of a growth spurt, but an MRI scan revealed the devastating diagnosis. Aubrey is currently undergoing radiotherapy at Bristol Children’s Hospital, and his parents are researching potential clinical trials for DIPG while fundraising for his treatments. DIPG symptoms include balance problems, weakness in limbs, speech and vision issues, and difficulty swallowing. The family is trying to remain hopeful while acknowledging the bleak prognosis associated with DIPG.
Gideon Beatty, a child from Great Falls, is battling leukemia, and his family is struggling with medical expenses and emotional challenges. Gideon's parents have faced financial strain and emotional turmoil while supporting their son through his treatment. They have set up a GoFundMe to help with expenses and are seeking support from the community.
A 13-year-old boy, Lucas Jemeljanova, has become the first person ever to be cured of a rare and aggressive form of brain cancer called diffuse intrinsic pontine glioma (DIPG). Previously considered terminal, Lucas participated in a study in France testing the effectiveness of three cancer drugs, and was treated with everolimus, which led to the complete disappearance of his tumor. Seven other children in the trial saw their tumors shrink, but Lucas was the only one whose tumor vanished entirely. Doctors are hopeful that his recovery may lead to new insights and treatments for this type of cancer.
A UK mom detected her infant son's rare and aggressive eye cancer, retinoblastoma, using the flash on her phone's camera, leading to his diagnosis and treatment. After noticing a white glow in his eye, she took photos and sought medical advice, ultimately leading to Thomas receiving six rounds of chemotherapy and overcoming the illness. The Childhood Eye Cancer Trust emphasizes the importance of recognizing subtle symptoms and signs of retinoblastoma for early detection and treatment.
Kevin Eaise, a college athlete, had a brain tumor as a child and underwent successful surgery performed by Dr. Phillip B. Storm. Now 24, Eaise works as a clinical research assistant at the same hospital, helping pediatric patients and their families while pursuing a medical career. His family foundation has raised almost $1 million for brain tumor research, and Eaise hopes to make a difference in pediatric care.
A 6-year-old Belgian boy, Lucas, has become the first child in the world to be cured of brain stem glioma, a rare and lethal form of cancer, after participating in an experimental treatment trial. The tumor completely disappeared following treatment with the drug everolimus, and researchers are now hoping to reproduce the genetic mutation in vitro to confirm the cause of Lucas' remarkable recovery. This breakthrough offers hope for improving long-term outcomes for children with this cancer, although an approved medication may not be available for another 10 to 15 years.
A 13-year-old boy from Belgium, Lucas Jemeljanova, has become the first person in the world to be cured of diffuse intrinsic pontine glioma (DIPG), a deadly form of childhood cancer, through a clinical trial using the chemotherapy drug everolimus. His tumor completely disappeared, and seven other children on the same trial are considered 'long responders.' Scientists are now studying the genetic abnormalities of patients’ tumors to recreate Lucas’ genetic differences in the lab and find a drug with a similar effect on tumor cells, but caution that this process could take 10-15 years.